Insiders Updates
SAGE’s latest rating updates from top analysts.
Sage Therapeutics Inc’s recent filing unveils that its Officer JONAS JEFFREY M acquired Company’s shares for reported $41441.0 on Dec
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.